Article

Molecular role of GATA binding protein 4 (GATA-4) in hyperglycemia-induced reduction of cardiac contractility.

Department of Medical Research, Chi-Mei Medical Center, No, 901 Chon-Hwa Road, Yong Kang, Tainan City, Taiwan.
Cardiovascular Diabetology (Impact Factor: 3.71). 06/2011; 10:57. DOI: 10.1186/1475-2840-10-57
Source: PubMed

ABSTRACT Diabetic cardiomyopathy, a diabetes-specific complication, refers to a disorder that eventually leads to left ventricular hypertrophy in addition to diastolic and systolic dysfunction. In recent studies, hyperglycemia-induced reactive oxygen species (ROS) in cardiomyocytes have been linked to diabetic cardiomyopathy. GATA binding protein 4 (GATA-4) regulates the expression of many cardio-structural genes including cardiac troponin-I (cTnI).
Streptozotocin-induced diabetic rats and H9c2 embryonic rat cardiomyocytes treated with a high concentration of glucose (a D-glucose concentration of 30 mM was used and cells were cultured for 24 hr) were used to examine the effect of hyperglycemia on GATA-4 accumulation in the nucleus. cTnI expression was found to be linked to cardiac tonic dysfunction, and we evaluated the expression levels of cTnI and GATA-4 by Western blot analysis.
Cardiac output was lowered in STZ-induced diabetic rats. In addition, higher expressions of cardiac troponin I (cTnI) and phosphorylated GATA-4 were identified in these rats by Western blotting. The changes were reversed by treatment with insulin or phlorizin after correction of the blood sugar level. In H9c2 cells, ROS production owing to the high glucose concentration increased the expression of cTnI and GATA-4 phosphorylation. However, hyperglycemia failed to increase the expression of cTnI when GATA-4 was silenced by small interfering RNA (siRNA) in H9c2 cells. Otherwise, activation of ERK is known to be a signal for phosphorylation of serine105 in GATA-4 to increase the DNA binding ability of this transcription factor. Moreover, GSK3β could directly interact with GATA-4 to cause GATA-4 to be exported from the nucleus. GATA-4 nuclear translocation and GSK3β ser9 phosphorylation were both elevated by a high glucose concentration in H9c2 cells. These changes were reversed by tiron (ROS scavenger), PD98059 (MEK/ERK inhibitor), or siRNA of GATA-4. Cell contractility measurement also indicated that the high glucose concentration decreased the contractility of H9c2 cells, and this was reduced by siRNA of GATA-4.
Hyperglycemia can cause systolic dysfunction and a higher expression of cTnI in cardiomyocytes through ROS, enhancing MEK/ERK-induced GATA-4 phosphorylation and accumulation in the cell nucleus.

0 Followers
 · 
165 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Increase of μ-opioid receptor (MOR) expression in liver of diabetic rats has been mentioned to associate with hyperglycemia that can activate the signal transducer and activator of transcription 3 (STAT3) pathway. Additionally, STAT3 may regulate the expression of MOR genes. In the present study, role of STAT3 in the regulation of increased MOR expression was investigated in diabetic rats and cultured rat skeletal myoblast (L6) cells. Streptozotocin-induced type 1-like diabetic rats (STZ rats) were used to estimate the response to MOR agonist (loperamide) and the changes in MOR expression. Then, cultured L6 cells incubated in high glucose (HG) medium were used to mimic the in vivo changes. Loperamide-induced hypoglycemia was more pronounced in STZ rats. The increased MOR expression in skeletal muscle of STZ rats was reversed by the reduction of hyperglycemia. Increased MOR expression and the enhanced expression of STAT3 observed in HG- exposed cultured L6 cells. Treatment with siRNA specific to STAT3 reversed the increased expression of MOR in this cell model. Treatment with stattic at a dose sufficient to inhibit STAT3 reversed MOR expression in STZ rats. We identified that hyperglycemia induces a greater expression of STAT3 to result in the increased expression of MOR, both in vivo and in vitro.
    Neuroscience Letters 09/2014; 582. DOI:10.1016/j.neulet.2014.09.008 · 2.06 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The cardiac insulin-like growth factor 2 receptor (IGF-2R) can induce cardiomyocyte hypertrophy in a heterotrimeric G protein receptor coupled manner involving αq (Gαq) or αs (Gαs). We have previously shown increased left ventricular weight and cardiac IGF-2 and IGF-2R gene expression in low birth weight (LBW) compared to average birth weight (ABW) lambs. Here we have investigated the cardiac expression of IGF-2 gene variants, degree of histone acetylation and abundance of proteins in the IGF-2R downstream signalling pathway in ABW and LBW lambs. Samples from the left ventricle of ABW and LBW lambs were collected at 21 d of age. There was increased phospho-CaMKII protein with decreased HDAC 4 abundance in the LBW compared to ABW lambs. There was increased GATA 4 and decreased phospho-troponin I abundance in LBW compared to ABW lambs, which are markers of pathological cardiac hypertrophy and impaired or reduced contractility, respectively. There was increased histone acetylation of H3K9 at IGF-2R promoter and IGF-2R intron 2 DMR in the LBW lamb. In conclusion, histone acetylation of IGF-2R may lead to increased IGF-2R mRNA expression and subsequently mediate Gαq signalling early in life via CaMKII resulting in an increased risk of left ventricular hypertrophy and cardiovascular disease in adult life. Copyright © 2014, American Journal of Physiology - Regulatory, Integrative and Comparative Physiology.
    AJP Regulatory Integrative and Comparative Physiology 01/2015; 308(7):ajpregu.00346.2014. DOI:10.1152/ajpregu.00346.2014 · 3.53 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Myosin binding protein H (MyBPH) is a protein of unknown function, which shares sequence and structural similarities with myosin binding protein C (cMyBPC), a protein frequently implicated in hypertrophic cardiomyopathy (HCM). Given the similarity between cMyBPC and MyBPH, we proposed that MyBPH, like cMyBPC, could be involved in HCM pathogenesis and we therefore sought to determine its function. We identified MyBPH-interacting proteins by using yeast two-hybrid (Y2H) analysis. The role of MyBPH and cMyBPC in cardiac cell contractility was analysed by measuring the planar cell surface area of differentiated H9c2 rat cardiomyocytes in response to β-adrenergic stress after siRNA knockdown of MyBPH and cMyBPC. Individual knockdown of either protein had no effect on cardiac contractility, while concurrent knockdowns reduced cardiac contractility. These proteins therefore functionally compensate for one another and are critical for cardiac contractility. We further show that both proteins co-localise with the autophagosomal membrane protein LC3, suggesting that both proteins are involved in autophagosomal membrane maturation processes. The results of this study ascribe novel functions to MyBPH, which may contribute to our understanding of its role in the sarcomere. This study provides evidence for a potential role of MyBPH in HCM, which warrants further investigation. Copyright © 2014. Published by Elsevier Inc.
    Experimental Cell Research 11/2014; 331(2). DOI:10.1016/j.yexcr.2014.11.006 · 3.37 Impact Factor